SCP fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Scope Fluidics SA engages in the research and development in the field of healthcare. It conducts projects for bacteria and virus detection, drug resistance and blood testing. The company's projects include PCR|ONE and BacterOMIC. Scope Fluidics was founded by Piotr Garstecki, Robert Piotr Holyst and Marcin Michal Izydorzak in 2010 and is headquartered in Warsaw, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
SCP does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company